A detailed history of D. E. Shaw & Co., Inc. transactions in Zimmer Biomet Holdings, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 490,138 shares of ZBH stock, worth $51.3 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
490,138
Previous 114,209 329.16%
Holding current value
$51.3 Million
Previous $15.1 Million 252.91%
% of portfolio
0.05%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$106.25 - $130.01 $39.9 Million - $48.9 Million
375,929 Added 329.16%
490,138 $53.2 Million
Q1 2024

May 15, 2024

SELL
$119.98 - $132.61 $5.72 Million - $6.33 Million
-47,701 Reduced 29.46%
114,209 $15.1 Million
Q4 2023

Feb 14, 2024

BUY
$102.72 - $121.7 $7.42 Million - $8.79 Million
72,252 Added 80.59%
161,910 $19.7 Million
Q3 2023

Nov 14, 2023

BUY
$110.76 - $143.18 $1.57 Million - $2.03 Million
14,150 Added 18.74%
89,658 $10.1 Million
Q2 2023

Aug 14, 2023

SELL
$126.43 - $145.6 $1.02 Million - $1.17 Million
-8,047 Reduced 9.63%
75,508 $11 Million
Q1 2023

May 15, 2023

BUY
$121.91 - $130.94 $8 Million - $8.59 Million
65,621 Added 365.9%
83,555 $10.8 Million
Q4 2022

Feb 14, 2023

SELL
$104.7 - $128.4 $6.55 Million - $8.03 Million
-62,531 Reduced 77.71%
17,934 $2.29 Million
Q3 2022

Nov 14, 2022

SELL
$101.65 - $119.27 $5.18 Million - $6.08 Million
-50,945 Reduced 38.77%
80,465 $8.41 Million
Q2 2022

Aug 15, 2022

SELL
$102.23 - $133.85 $28.9 Million - $37.9 Million
-282,837 Reduced 68.28%
131,410 $13.8 Million
Q1 2022

May 16, 2022

SELL
$108.42 - $129.58 $66 Million - $78.9 Million
-608,786 Reduced 59.51%
414,247 $53 Million
Q4 2021

Feb 14, 2022

BUY
$115.43 - $146.63 $39.2 Million - $49.8 Million
339,531 Added 49.68%
1,023,033 $130 Million
Q3 2021

Nov 15, 2021

SELL
$136.35 - $158.76 $34.2 Million - $39.8 Million
-250,622 Reduced 26.83%
683,502 $100 Million
Q2 2021

Aug 16, 2021

BUY
$152.95 - $173.41 $62.6 Million - $71 Million
409,523 Added 78.06%
934,124 $150 Million
Q1 2021

May 17, 2021

BUY
$148.16 - $159.71 $31.8 Million - $34.2 Million
214,359 Added 69.09%
524,601 $84 Million
Q4 2020

Feb 16, 2021

BUY
$128.25 - $151.41 $16.6 Million - $19.6 Million
129,412 Added 71.57%
310,242 $47.8 Million
Q3 2020

Nov 16, 2020

SELL
$113.59 - $141.68 $12.4 Million - $15.5 Million
-109,157 Reduced 37.64%
180,830 $24.6 Million
Q2 2020

Aug 14, 2020

SELL
$87.02 - $133.4 $11.3 Million - $17.3 Million
-129,402 Reduced 30.85%
289,987 $34.6 Million
Q1 2020

May 15, 2020

BUY
$78.28 - $155.73 $22 Million - $43.9 Million
281,621 Added 204.42%
419,389 $42.4 Million
Q4 2019

Feb 14, 2020

SELL
$127.4 - $146.83 $4.9 Million - $5.65 Million
-38,450 Reduced 21.82%
137,768 $20.6 Million
Q3 2019

Nov 14, 2019

SELL
$113.33 - $138.46 $74.9 Million - $91.5 Million
-660,771 Reduced 78.95%
176,218 $24.2 Million
Q2 2019

Aug 14, 2019

BUY
$108.87 - $125.09 $51.8 Million - $59.5 Million
475,656 Added 131.64%
836,989 $98.5 Million
Q1 2019

May 15, 2019

SELL
$97.5 - $125.79 $42 Million - $54.2 Million
-430,740 Reduced 54.38%
361,333 $46.1 Million
Q4 2018

Feb 14, 2019

BUY
$94.4 - $126.76 $34 Million - $45.7 Million
360,267 Added 83.43%
792,073 $82.2 Million
Q3 2018

Nov 14, 2018

BUY
$108.41 - $127.64 $7.78 Million - $9.15 Million
71,724 Added 19.92%
431,806 $56.8 Million
Q2 2018

Aug 14, 2018

BUY
$102.12 - $114.04 $6.05 Million - $6.76 Million
59,287 Added 19.71%
360,082 $40.1 Million
Q1 2018

May 15, 2018

SELL
$104.31 - $124.46 $198,710 - $237,096
-1,905 Reduced 0.63%
300,795 $32.8 Million
Q4 2017

Feb 14, 2018

BUY
$105.55 - $120.83 $8.77 Million - $10 Million
83,112 Added 37.85%
302,700 $36.5 Million
Q3 2017

Nov 14, 2017

BUY
$106.92 - $117.79 $23.5 Million - $25.9 Million
219,588
219,588 $25.7 Million

Others Institutions Holding ZBH

About ZIMMER BIOMET HOLDINGS, INC.


  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $22B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.